Jim Cramer on Smith & Nephew: “This Group, I Do Not Like”

Smith & Nephew plc (NYSE:SNN) is one of the stocks Jim Cramer recently looked at. When a caller inquired about the stock, Cramer was quick to say:

They have to, they have to be sold, okay? I just, this group, I do not like. Okay, I just don’t like them because it’s commoditized, alright? I remember I asked my wife… she got a new knee, I said, well, who’d you use? Which one? She goes, it doesn’t matter. And that’s the answer.

Pixabay/Public Domain

Smith & Nephew plc (NYSE:SNN) manufactures medical technologies, including joint implants, sports medicine repair tools, and visualization systems for minimally invasive surgeries.

While we acknowledge the risk and potential of SNN as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. If you are looking for an AI stock that is more promising than SNN and that has 10,000% upside potential, check out our report about this cheapest AI stock.

READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now.

Disclosure: None. This article is originally published at Insider Monkey.